Meeting
2023 ASCO Genitourinary Cancers Symposium
Optimal treatment by invoking biologic clusters in renal cell carcinoma (OPTIC RCC).
Authors
Yu-Wei Chen
Vanderbilt University Medical Center, Nashville, TN
Yu-Wei Chen , Katy Beckermann , Scott Mattox Haake , Anupama Reddy , Yu Shyr , Michael B. Atkins , Nataliya Mar , Moshe Chaim Ornstein , Sumanta Monty Pal , Tian Zhang , Wendy Kimryn Rathmell , Brian I. Rini
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
NCT05361720
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr TPS742)
DOI
10.1200/JCO.2023.41.6_suppl.TPS742
Abstract #
TPS742
Poster Bd #
M20
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Biomarker-driven prospective clinical trial in renal cell carcinoma: Developing machine learning models to allocate patients to treatment arms using RNA sequencing.
First Author: Anupama Reddy
Poster
2023 ASCO Genitourinary Cancers Symposium
Impact of sarcomatoid features on treatment outcomes in metastatic clear cell renal cell carcinoma treated with first-line immunotherapy combinations.
First Author: Kelly N. Fitzgerald
Poster
2023 ASCO Genitourinary Cancers Symposium
A pilot trial evaluating the rapid sequencing of approved therapies in patients (pts) with advanced clear cell renal cell carcinoma (ccRCC).
First Author: Qian Qin
First Author: Scott Mattox Haake